Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma

M. Fedorko, M. Stanik, R. Iliev, M. Redova-Lojova, T. Machackova, M. Svoboda, D. Pacik, J. Dolezel, O. Slaby,

. 2015 ; 16 (10) : 23382-23389. [pub] 20150929

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16028160

Grantová podpora
NT13547 MZ0 CEP - Centrální evidence projektů
NV15-34678A MZ0 CEP - Centrální evidence projektů

Serum microRNAs are emerging as a clinically useful tool for early and non-invasive detection of various cancer types including renal cell carcinoma (RCC). Based on our previous results, we performed the study to analyze circulating serum miR-378 and miR-210 in patients with various histological subtypes of RCC. RNA was purified from blood serum samples of 195 RCC patients and 100 healthy controls. The levels of miR-378 and miR-210 in serum were determined absolutely using quantitative real-time PCR. Pre- and postoperative levels of both microRNAs were compared in 20 RCC patients. Significantly increased serum levels of both miR-378 and miR-210 enabled to clearly distinguish RCC patients and healthy controls with 80% sensitivity and 78% specificity if analyzed in combination (p<0.0001), and their levels significantly decreased in the time period of three months after radical nephrectomy (p<0.0001). Increased level of miR-378 positively correlates with disease-free survival (p=0.036) and clinical stage (p=0.0476). The analysis of serum miR-378 and miR-210 proved their potential to serve as powerful non-invasive diagnostic and prognostic biomarkers in RCC.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16028160
003      
CZ-PrNML
005      
20201116155346.0
007      
ta
008      
161005s2015 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms161023382 $2 doi
024    7_
$a 10.3390/ijms161023382 $2 doi
035    __
$a (PubMed)26426010
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Fedorko, Michal $u Department of Urology, University Hospital Brno and Masaryk University Brno, Brno 62500, Czech Republic. michal.fedorko@fnbrno.cz. $7 xx0121526
245    10
$a Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma / $c M. Fedorko, M. Stanik, R. Iliev, M. Redova-Lojova, T. Machackova, M. Svoboda, D. Pacik, J. Dolezel, O. Slaby,
520    9_
$a Serum microRNAs are emerging as a clinically useful tool for early and non-invasive detection of various cancer types including renal cell carcinoma (RCC). Based on our previous results, we performed the study to analyze circulating serum miR-378 and miR-210 in patients with various histological subtypes of RCC. RNA was purified from blood serum samples of 195 RCC patients and 100 healthy controls. The levels of miR-378 and miR-210 in serum were determined absolutely using quantitative real-time PCR. Pre- and postoperative levels of both microRNAs were compared in 20 RCC patients. Significantly increased serum levels of both miR-378 and miR-210 enabled to clearly distinguish RCC patients and healthy controls with 80% sensitivity and 78% specificity if analyzed in combination (p<0.0001), and their levels significantly decreased in the time period of three months after radical nephrectomy (p<0.0001). Increased level of miR-378 positively correlates with disease-free survival (p=0.036) and clinical stage (p=0.0476). The analysis of serum miR-378 and miR-210 proved their potential to serve as powerful non-invasive diagnostic and prognostic biomarkers in RCC.
650    _2
$a nádorové biomarkery $x krev $7 D014408
650    _2
$a karcinom z renálních buněk $x krev $x genetika $7 D002292
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a lidé $7 D006801
650    _2
$a nádory ledvin $x krev $x genetika $7 D007680
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x krev $7 D035683
650    _2
$a lidé středního věku $7 D008875
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Staník, Michal, $u Department of Urologic Oncology, Masaryk Memorial Cancer Institute, Brno 65653, Czech Republic. stanik@mou.cz. $d 1977- $7 xx0141428
700    1_
$a Iliev, Robert $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno 65653, Czech Republic. 269069@mail.muni.cz. Central European Institute of Technology, Masaryk University, Brno 62500, Czech Republic. 269069@mail.muni.cz. $7 _AN063401
700    1_
$a Lojová, Martina, $u Central European Institute of Technology, Masaryk University, Brno 62500, Czech Republic. martina.redova@gmail.com. $d 1983- $7 mub2011663118
700    1_
$a Machackova, Tana $u Central European Institute of Technology, Masaryk University, Brno 62500, Czech Republic. tana.machackova@gmail.com.
700    1_
$a Svoboda, Marek, $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno 65653, Czech Republic. msvoboda@mou.cz. $d 1975- $7 xx0098478
700    1_
$a Pacík, Dalibor, $u Department of Urology, University Hospital Brno and Masaryk University Brno, Brno 62500, Czech Republic. dalibor.pacik@gmail.com. $d 1955- $7 nlk19990073648
700    1_
$a Doležel, Jan, $u Department of Urologic Oncology, Masaryk Memorial Cancer Institute, Brno 65653, Czech Republic. dolezel@mou.cz. $d 1956- $7 xx0064982
700    1_
$a Slabý, Ondřej, $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno 65653, Czech Republic. slaby@mou.cz. Central European Institute of Technology, Masaryk University, Brno 62500, Czech Republic. slaby@mou.cz. $d 1981- $7 js20030220015
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 16, č. 10 (2015), s. 23382-23389
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26426010 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20201116155344 $b ABA008
999    __
$a ok $b bmc $g 1166474 $s 952790
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 16 $c 10 $d 23382-23389 $e 20150929 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a NT13547 $p MZ0
GRA    __
$a NV15-34678A $p MZ0
LZP    __
$a Pubmed-20161005

Najít záznam

Citační ukazatele

Možnosti archivace